Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
BioNTech (BNTX US)
Watchlist
25
Analysis
Health Care
•
Germany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
BioNTech
•
16 Aug 2024 19:49
BioNTech SE: Expansion of MRNA Technology Applications & Major Drivers
BioNTech's second quarter of 2024 earnings revealed a company navigating both ongoing strides in its primary COVID-19 vaccine franchise and...
Baptista Research
Follow
314 Views
Share
bullish
•
BioNTech
•
10 Jul 2024 06:01
BioNTech SE: Expansion into Oncology and Cancer Therapies & Other Major Drivers
BioNTech's First Quarter 2024 Earnings Call highlighted a strategic focus on their late-stage oncology pipeline and continued initiatives...
Baptista Research
Follow
184 Views
Share
bullish
•
BioNTech
•
01 Apr 2024 14:17
BioNTech SE: How Its Strengthened Pipeline & Portfolio Is Changing The Game!
This is our first report on biotechnology major, BioNTech. The company recently reported its fourth quarter and full-year 2023 earnings. BioNTech...
Baptista Research
Follow
223 Views
Share
bullish
•
Moderna
•
20 Jan 2022 23:30
Is It Time For Moderna To Boost Share Buyback And Start Paying Dividends?
Our analysis suggests that Moderna may boost share buyback and announce dividend payments in 2022 as cash pile will exceed $20 billion
Andrei Zakharov
Follow
359 Views
Share
bullish
•
Moderna
•
04 Dec 2021 17:57
Moderna (MRNA US): To Cash in on Omicron Fear
Moderna is set to fly high on the continuous increasing demand for its Covid vaccine and rich pipeline beyond Covid. Emerging Omicron variant is...
Tina Banerjee
Follow
419 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x